United Therapeutics UTHR Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is United Therapeutics's total current liabilities?
- United Therapeutics (UTHR) reported total current liabilities of $599.1M in Q1 2026.
- How has United Therapeutics's total current liabilities changed year-over-year?
- United Therapeutics's total current liabilities decreased by 17.0% year-over-year, from $721.5M to $599.1M.
- What is the long-term trend for United Therapeutics's total current liabilities?
- Over 5 years (2020 to 2025), United Therapeutics's total current liabilities has grown at a 11.6% compound annual growth rate (CAGR), from $323.3M to $560.6M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.